Shortcut Navigation:

Breast Cancer News

In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.

"Chemo brain" may persist years after treatment

NEW YORK (Reuters Health) - Women on chemotherapy for breast cancer may have tiny memory and thinking impairments compared with cancer-free women more than 20 years after their treatment, Dutch researchers have found.

Astra takes brand cancer drug straight to patients

(Reuters) - AstraZeneca Plc is selling breast cancer drug Arimidex directly to U.S. patients, offering an option for people who want to pay for the brand instead of generic versions.

Older Women Benefit Less from Treatment Breakthroughs

Women 65 and older are less likely to survive breast cancer than their younger counterparts, two recent studies suggest.

Rare mutations tied to breast, pancreatic cancers

NEW YORK (Reuters Health) - Mutations in genes that fix mismatched DNA may put people at extra risk for breast cancer and pancreatic cancer, in addition to their well-known ties to colon and endometrial cancers, a new report suggests.

Most women with cancer want a role in decisions

NEW YORK (Reuters Health) - About two-thirds of women diagnosed with early stage breast cancer want to take part in making decisions about their treatment, according to a new survey of patients from five different countries.

Breast cancer kills older women more often

NEW YORK (Reuters Health) - Breast cancer is often considered more deadly among younger women, but a new study shows older women are actually more likely to die of the disease.

FDA staff unsure about new use for Amgen's Xgeva

WASHINGTON (Reuters) - Reviewers from the U.S. Food and Drug Administration said on Monday that they were not sure whether Amgen Inc's Xgeva bone drug should be approved for a wider use of delaying the spread of cancer to the bone.

Medicine Combination Slows Metastatic Hormone Positive Breast Cancer

Learn how the combination of everolimus and the hormonal therapy exemestane may offer a new treatment option for postmenopausal women with locally advanced or metastatic estrogen-receptor positive, HER2-negative breast cancer.

Re-operation common after breast-conserving surgery

NEW YORK (Reuters Health) - One in four women who have breast-conserving surgery for cancer needs a second operation to remove more breast tissue, suggests a new study that also found the rate of re-operation varied widely by surgeon.

Medicine Combination Slows Metastatic HER2 Positive Breast Cancer

Learn how the experiemental medicine pertuzumab improves progression-free survival and may offer a new treatment option for women with metastatic HER2 positive breast cancer.